Macrolides for treating diseases mediated through PDE inhibition

Details for Australian Patent Application No. 2009211333 (hide)

Owner Basilea Pharmaceutica AG

Inventors Reinelt, Stefan Bernhard; Dreier, Jurg; Kellenberger, Johannes Laurenz

Agent Spruson & Ferguson

Pub. Number AU-A-2009211333

PCT Pub. Number WO2009/098320

Priority 08101444.1 08.02.08 EP

Filing date 9 February 2009

Wipo publication date 13 August 2009

International Classifications

A61K 31/7048 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/098320 Priority application(s): WO2009/098320

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211338-Pyrrolo[2, 3-D]pyrimidines and use thereof as tyrosine kinase inhibitors

2009211331-Liquid formulation of FSH